United States · Law · HR
H.R. 4374 (115th)
To amend the Federal Food, Drug, and Cosmetic Act to authorize additional emergency uses for medical products to reduce deaths and severity of injuries caused by agents of war, and for other purposes.
Introduced
13 November 2017
Last action
—
Status
Became Public Law No: 115-92.
Sponsors
—
Subjects
Discovery layer
Source updated
6 June 2025
Summary
This bill amends the Federal Food, Drug, and Cosmetic Act to allow the Food and Drug Administration (FDA) to authorize the emergency use of an otherwise unapproved medical product if the Department of Defense (DOD) determines that there is a military emergency involving an agent that may cause imminently life-threatening and specific risk to U.S. forces. If a military emergency is determined to exist, the bill allows DOD to request that the FDA expedite certain procedures for approving medical products that would be reasonably likely to diagnose, prevent, treat, or mitigate such risk. The FDA must take specified actions to facilitate such a request by DOD. The bill repeals provisions of the National Defense Authorization Act for Fiscal Year 2018 that allow DOD, rather than the FDA, to authorize the emergency use of an unapproved product under similar circumstances. Unless DOD determines such meetings to be unnecessary, the FDA shall meet with DOD: (1) semi-annually to conduct a full review of relevant medical products in the DOD portfolio; and (2) quarterly to discuss the development status of regenerative medicine advanced therapy, blood, and vaccine medical products and projects that DOD prioritizes.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
14 official files
Enrolled Bill (text)
Enrolled Bill (text)
Enrolled Bill · EN
Enrolled Bill (PDF)
Enrolled Bill · EN
Public Law (text)
Public Law · EN · 12 December 2017
Public Law (PDF)
Public Law · EN · 12 December 2017
Public Law
summary · EN · 12 December 2017
Passed Senate without amendment
summary · EN · 16 November 2017
Received in Senate (text)
Received in Senate · EN · 15 November 2017
Received in Senate (PDF)
Received in Senate · EN · 15 November 2017
Engrossed in House (text)
Engrossed in House · EN · 15 November 2017
Engrossed in House (PDF)
Engrossed in House · EN · 15 November 2017
Passed House without amendment
summary · EN · 15 November 2017
Introduced in House (text)
Introduced in House · EN · 13 November 2017
Introduced in House (PDF)
Introduced in House · EN · 13 November 2017
Introduced in House
summary · EN · 13 November 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/house-bill/4374
- Open data entity: https://api.congress.gov/v3/bill/115/hr/4374